An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation

By Kaashoek M.J.   Moerman A.   Madic J.   Weerdmeester K.   Maris-Veldhuis M.   Rijsewijk F.A.M.   van Oirschot J.T.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 342-346

Elsevier

Access to resources Recommend Favorite

A classical inactivated vaccine induces protection against caprine herpesvirus 1 infection in goats

By Tempesta M.   Camero M.   Greco G.   Pratelli A.   Martella V.   Buonavoglia C.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3860-3864

Elsevier

Access to resources Recommend Favorite

The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases

By Donners H.   Vermoesen T.   Willems B.   Davis D.   van der Groen G.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 104-111

Elsevier

Access to resources Recommend Favorite

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva

By NIAID AIDS   Gorse G.J.   Rogers J.H.   Perry J.E.   Newman F.K.   Frey S.E.   Patel G.B.   Belshe R.B.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 209-214

Elsevier

Access to resources Recommend Favorite

The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains

By Ala'Aldeen D.A.A.   Borriello S.P.  

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 49-53

Elsevier

Access to resources Recommend Favorite